Market Overview:
The global biomaterials in plastic surgery market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth of this market is mainly attributed to the increasing demand for minimally invasive surgeries and rising prevalence of chronic diseases. In addition, the growing geriatric population and technological advancements are also contributing to the growth of this market. On the basis of type, facial wrinkle treatment was the largest segment in 2017 and is expected to maintain its dominance during the forecast period. This segment is mainly driven by increasing demand for anti-aging treatments among consumers across all regions.
Product Definition:
A biomaterial is any substance that has been engineered to interact with the body for a therapeutic, diagnostic, or other purpose.
Surgical implants: Biomaterials can be used as surgical implants to replace or augment tissue in the body. For example, surgeons may use an implant made from silicone to correct breast deformities.
Blood substitutes: Biomaterials can also be used as blood substitutes in cases where traditional blood transfusions are not possible. One example of this is hemoglobin-based oxygen carriers (HBOCs), which are made from synthetic materials and can help improve the oxygen supply to tissues during surgery.
Facial Wrinkle Treatment:
Facial wrinkles are caused by the movement of facial muscles and skin overlying it. These wrinkles occur mainly on the face, but can also be found on other parts of the body such as neck, hands and feet. The treatment for facial wrinkles is called rejuvenation or rejuvenation plastic surgery which includes surgical procedures to improve structure & function of aged tissues. Some patients may require only medical therapy while others may require both medical therapy and surgical procedure(s).
Soft Tissue Fillers:
Soft tissue fillers, also known as autologous or allogeneic filler is a medical procedure where the surgeon injects or implants a substance to replace damaged soft tissues in another part of the body. Soft tissue fillers are used for augmentation and reconstruction surgeries. The most common areas that require soft tissue fillers are face, neck, hands, feet and lower extremities.
The global soft tissue filler market size was valued at USD 2 billion in 2015.
Application Insights:
Based on application, the market is segmented into hospitals, clinics, and others. Hospitals held the largest share in 2017 as they are considered to be the most prominent centers for surgeries involving body parts such as faces or hands. These institutions have highly skilled teams of surgeons that are equipped with advanced surgical tools and techniques. Thus, these hospitals account for a major share in overall revenue due to their large patient base requiring various types of plastic surgeries over their bodies¢â‚¬â„¢ anatomies.
Regional Analysis:
North America dominated the global market in 2017. The growth can be attributed to rising demand for cosmetic surgeries, increasing awareness about reconstructive surgery and growing medical tourism in the region. Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising healthcare expenditure by governments and private sectors, improving economic conditions, increased per capita income levels coupled with high unmet needs of patients seeking biomaterials based treatment for various disorders.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The trend of minimally invasive surgeries is increasing worldwide due to various benefits such as shorter hospital stays, reduced pain and blood loss, and faster recovery times. This is benefiting the biomaterials market as these products are extensively used in minimally invasive surgeries.
- Rising prevalence of chronic diseases: The incidence of chronic diseases such as cancer, cardiovascular diseases, and orthopedic disorders is rising globally due to changing lifestyles and aging population. This is leading to an increase in the demand for plastic surgery procedures which in turn is propelling the growth of biomaterials market.
- Growing awareness about aesthetic procedures: There has been a significant rise in the number of people opting for aesthetic procedures such as liposuction, breast augmentation, and rhinoplasty over the past few years owing to growing awareness about their benefits. This is providing a major impetus to the growth of biomaterials market in plastic surgery sector.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biomaterials in Plastic Surgery Market Research Report
By Type
Facial Wrinkle Treatment, Soft Tissue Fillers, Craniofacial Surgery, Bioengineered Skins, Peripheral Nerve Repair, Acellular Dermal Matrices, Others
By Application
Hospitals, Clinics, Others
By Companies
Medtronic plc, Evonik Industries AG, Carpenter Technology Corporation, Berkeley Advanced Biomaterials, Invibio Ltd., Zimmer Biomet Holdings, Inc., BASF SE, Covalon Technologies Ltd., Stryker, Johnson & Johnson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Biomaterials in Plastic Surgery Market Report Segments:
The global Biomaterials in Plastic Surgery market is segmented on the basis of:
Types
Facial Wrinkle Treatment, Soft Tissue Fillers, Craniofacial Surgery, Bioengineered Skins, Peripheral Nerve Repair, Acellular Dermal Matrices, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic plc
- Evonik Industries AG
- Carpenter Technology Corporation
- Berkeley Advanced Biomaterials
- Invibio Ltd.
- Zimmer Biomet Holdings, Inc.
- BASF SE
- Covalon Technologies Ltd.
- Stryker
- Johnson & Johnson
Highlights of The Biomaterials in Plastic Surgery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Facial Wrinkle Treatment
- Soft Tissue Fillers
- Craniofacial Surgery
- Bioengineered Skins
- Peripheral Nerve Repair
- Acellular Dermal Matrices
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biomaterials in Plastic Surgery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biomaterials are materials that have been specifically designed to be used in plastic surgery. These materials can help improve the look and function of a patient's skin after surgery.
Some of the major companies in the biomaterials in plastic surgery market are Medtronic plc, Evonik Industries AG, Carpenter Technology Corporation, Berkeley Advanced Biomaterials, Invibio Ltd., Zimmer Biomet Holdings, Inc., BASF SE, Covalon Technologies Ltd., Stryker, Johnson & Johnson.
The biomaterials in plastic surgery market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biomaterials in Plastic Surgery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biomaterials in Plastic Surgery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biomaterials in Plastic Surgery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biomaterials in Plastic Surgery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biomaterials in Plastic Surgery Market Size & Forecast, 2020-2028
4.5.1 Biomaterials in Plastic Surgery Market Size and Y-o-Y Growth
4.5.2 Biomaterials in Plastic Surgery Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Facial Wrinkle Treatment
5.2.2 Soft Tissue Fillers
5.2.3 Craniofacial Surgery
5.2.4 Bioengineered Skins
5.2.5 Peripheral Nerve Repair
5.2.6 Acellular Dermal Matrices
5.2.7 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biomaterials in Plastic Surgery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biomaterials in Plastic Surgery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Facial Wrinkle Treatment
9.6.2 Soft Tissue Fillers
9.6.3 Craniofacial Surgery
9.6.4 Bioengineered Skins
9.6.5 Peripheral Nerve Repair
9.6.6 Acellular Dermal Matrices
9.6.7 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Facial Wrinkle Treatment
10.6.2 Soft Tissue Fillers
10.6.3 Craniofacial Surgery
10.6.4 Bioengineered Skins
10.6.5 Peripheral Nerve Repair
10.6.6 Acellular Dermal Matrices
10.6.7 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Facial Wrinkle Treatment
11.6.2 Soft Tissue Fillers
11.6.3 Craniofacial Surgery
11.6.4 Bioengineered Skins
11.6.5 Peripheral Nerve Repair
11.6.6 Acellular Dermal Matrices
11.6.7 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Facial Wrinkle Treatment
12.6.2 Soft Tissue Fillers
12.6.3 Craniofacial Surgery
12.6.4 Bioengineered Skins
12.6.5 Peripheral Nerve Repair
12.6.6 Acellular Dermal Matrices
12.6.7 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Facial Wrinkle Treatment
13.6.2 Soft Tissue Fillers
13.6.3 Craniofacial Surgery
13.6.4 Bioengineered Skins
13.6.5 Peripheral Nerve Repair
13.6.6 Acellular Dermal Matrices
13.6.7 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biomaterials in Plastic Surgery Market: Competitive Dashboard
14.2 Global Biomaterials in Plastic Surgery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic plc
14.3.2 Evonik Industries AG
14.3.3 Carpenter Technology Corporation
14.3.4 Berkeley Advanced Biomaterials
14.3.5 Invibio Ltd.
14.3.6 Zimmer Biomet Holdings, Inc.
14.3.7 BASF SE
14.3.8 Covalon Technologies Ltd.
14.3.9 Stryker
14.3.10 Johnson & Johnson
